Ekso Bionics Holdings, Inc. (EKSO) Accused of Implementing Unreliable Internal Controls
On December 14, 2017, Ekso Bionics Holdings, Inc. (EKSO) disclosed that its internal control over financial reporting as of December 31, 2016 should not be relied upon. According to the complaint, Ekso cited a reevaluation of the company’s information technology controls by the company’s auditor. On December 27, 2017, Ekso filed its amended annual report for 2016 and amended quarterly reports for the first three quarters of 2017. Since news of Ekso’s financial troubles became public, the company’s stock declined nearly 25%, and has yet to recover, closing at $1.86 per share on July 3, 2018.
Ekso Bionics Holdings, Inc. (EKSO) Shareholders Have Legal Options
Concerned shareholders who would like more information about their rights and potential remedies send us a message via the Shareholder Information form below.